Recent Finacing
Recent Raise
Delinia develops protein therapeutics that selectively expand and potentiate regulatory T cells to restore immune regulation in autoimmune and inflammatory diseases, using a targeted Treg activation platform.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors